Macrofollicular variant of papillary thyroid carcinoma: A case and control analysis

被引:13
作者
GamboaDominguez, A
VieitezMartinez, I
BarredoPrieto, BA
RichaudPatin, Y
Herrera, MF
AngelesAngeles, A
机构
[1] INST NACL NUTR SALVADOR ZUBIRAN,DEPT IMMUNOL & RHEUMATOL,MEXICO CITY 14000,DF,MEXICO
[2] INST NACL NUTR SALVADOR ZUBIRAN,DIV SURG,MEXICO CITY 14000,DF,MEXICO
关键词
macrofollicular variant of papillary thyroid carcinoma; planimetry; immunohistochemistry; flow cytometry;
D O I
10.1007/BF02739837
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The planimetric, flow cytometric, and immunohistochemical characteristics of the macrofollicular variant of papillary thyroid carcinoma (MFVPTC) have not been reported before. The clinical, morphological, immunohistochemical, planimetric, and flow cytometric characteristics of six cases of the MFVPTC and six of the follicular variant of papillary thyroid carcinoma (FVPTC) were analyzed. Patients had undergone surgical treatment, The mean age was 38 (range 29-64 yr), and five were women. Tumors had a mean size of 3.2 cm (range 0.3-4.5 cm). Half were originally diagnosed as goiter. Macrofollicles had a mean diameter of 345.5 mu m, perimeter of 1237 mu m, and area of 13,779 mu m(2), with nuclear changes of PTC. Mean follow-up was 107 mo (range 12-277), and neither lymph node metastases nor recurrence were seen. Differences in diameter, perimeter, and area between the macrofollicular and follicular variants were found. Follicular neoplastic cells were thyroglobulin and S-100 protein positive in macrofollicles and normofollicles. All were negative to cytokeratin and to high-mol-wt keratin. All tumors were diploid. There were no significant differences in follow-up, DNA content, nor immunohistochemical reactivity. Differences in diameter (p < 0.00006), perimeter (p < 0.0001), and area (p < 0.001) were observed. It is important to recognize this variant because it could be misdiagnosed as benign thyroidal lesions.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 21 条
[1]
THE MACROFOLLICULAR VARIANT OF PAPILLARY THYROID-CARCINOMA - A STUDY OF 17 CASES [J].
ALBORESSAAVEDRA, J ;
GOULD, E ;
VARDAMAN, C ;
VUITCH, F .
HUMAN PATHOLOGY, 1991, 22 (12) :1195-1205
[2]
PROGNOSTIC VALUE OF MORPHOMETRY IN PAPILLARY THYROID-CARCINOMA [J].
AMBROS, RA ;
TROST, RC ;
CAMPBELL, AY ;
LAMBERT, WC .
HUMAN PATHOLOGY, 1989, 20 (03) :215-218
[3]
DIFFUSE SCLEROSING VARIANT OF PAPILLARY THYROID-CARCINOMA - CLINICOPATHOLOGIC STUDY OF 15 CASES [J].
CARCANGIU, ML ;
BIANCHI, S .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (12) :1041-1049
[4]
CARCANGIU ML, 1985, CANCER, V55, P805, DOI 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO
[5]
2-Z
[6]
FOLLICULAR VARIANT OF THYROID PAPILLARY CARCINOMA - CLINICOPATHOLOGIC STUDY OF 6 CASES [J].
CHEN, KTK ;
ROSAI, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1977, 1 (02) :123-130
[8]
Papillary thyroid carcinoma in Mexican patients: Clinical aspects and prognostic factors [J].
Herrera, MF ;
LopezGraniel, CM ;
Saldana, J ;
GamboaDominguez, A ;
RichaudPatin, Y ;
VargasVorackova, F ;
AngelesAngeles, A ;
Llorente, L ;
Castillo, C ;
Perez, B ;
Rivera, R ;
Gonzalez, O ;
Rull, J .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :94-100
[9]
HODA SA, 1993, LAB INVEST, V68, pA38
[10]
JOENSUU H, 1986, CANCER, V58, P2462, DOI 10.1002/1097-0142(19861201)58:11<2462::AID-CNCR2820581119>3.0.CO